Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Topic of the Month April: Infectious diseases

Dear Sir or Madam,

Pathogens are everywhere and it is hardly possible to evade them. However, this can lead to problems, particularly in hospitals, since there are many immune-deficient people. Good hospital hygiene is important here. In addition, further research is needed. New antibiotics, faster diagnostics and the latest medical technology are urgently needed. Find out more in our Topic of the Month April "Infectious diseases – the laboratory races pathogens".

Have a wonderful day!

Simone Ernst
Editorial team MEDICA-tradefair.com


MEDICA Trade Fair with Forums and Conferences
Monday to Thursday
13 to 16 November 2017
Düsseldorf, Germany

Table of Contents

Topic of the Month: Infectious diseases
Video: Light instead of darkness
Newsletter Service
RSS Service
Newsletter Archive

Infectious diseases – the laboratory races pathogens

Topic of the Month

Image: Three young female scientists in a laboratory; Copyright: panthermedia.net/Viktor Cap
Infectious diseases come unnoticed and can have severe consequences. Prevention through good hygiene is the best protection for people in hospitals. This is especially necessary for weakened patients whose immune systems are not able to fight back the infections by themselves. When they still fall ill, physicians need to be quick to diagnose and treat them. Learn in our Topic of the Month, which role modern laboratory medicine plays here today.
Read more in our Topic of the Month:
Infectious diseases – the laboratory races pathogens
To top

Research & Technology

Researchers demonstrate value of second opinions

Many patients come to Mayo Clinic for a second opinion or diagnosis confirmation before treatment for a complex condition. In a study, Mayo Clinic reports that as many as 88 percent of those patients go home with a new or refined diagnosis -- changing their care plan and potentially their lives. Conversely, only 12 percent receive confirmation that the original diagnosis was complete and correct.
read more
To top

Research & Technology

Studying the brain's suspension system in TBIs

Traumatic brain injury, or TBI, can be devastating and debilitating. Despite intense interest and years of study, the exact mechanisms linking force and neurological injury remain unclear.
read more
To top

Research & Technology

Mini X-ray sensor for high-precision medical applications

The ability to detect X-rays on a tiny scale paves the way for high-precision medical imaging and therapies. Such detection capabilities have been achieved by researchers from the CNRS, the University of Franche-Comté (UFC), and Aix-Marseille University (AMU), who attached an X-ray sensor to the end of an optical fiber. Their work was published in "Optics Letters".
read more
To top

Light instead of darkness – Seeing with the Argus II Implant

Video

Image: Preview picture of video "Light instead of darkness"
Retinitis pigmentosa is a hereditary eye disorder, which can lead to night blindness, restriction of the peripheral visual field and ultimately to blindness. The University Hospital Aachen, Germany, implants the Argus II retinal prosthesis system made by the Second Sight Company. It allows people with retinitis pigmentosa to perceive light and improve orientation.
Click here for the video!
Light instead of darkness – Seeing with the Argus II Implant
See more reports in our MediaCenter!
To top

Public Health & Associations

Infant vitamin B1 deficiency leads to poor motor function and balance

A new Tel Aviv University study published in Maternal and Child Nutrition found that infantile Vitamin B1 (thiamine) deficiency severely affected the motor function of preschoolers who were fed faulty formula in the first year of their lives. The conclusions were based on a retrospective study of children who received Remedia, an Israeli formula brand completely lacking in Vitamin B1, in 2004.
read more
To top

Public Health & Associations

Asthmatic schoolchildren are 'uncomfortable' using their inhalers

Poor asthma control and knowledge are common in children with doctor-diagnosed asthma, according to research by Queen Mary University of London. In a survey of nearly 700 secondary schoolchildren, half of them were not controlling their asthma optimally, a third with an inhaler said they were uncomfortable using it at school, and almost a third with an inhaler did not use it even when wheezy.
read more
To top

Company News

Distribution Agreement with Hologic for Tumark clipmarker

SOMATEX Medical Technologies GmbH

Berlin, Germany — April 3, 2017— SOMATEX® Medical Technologies GmbH today announced a distribution partnership agreement with Hologic, Inc., a leading provider of medical imaging systems, effective...
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top

beta-web GmbH - Partner of Messe Düsseldorf

Advertising Opportunities

As an official partner of Messe Düsseldorf, beta-web markets exclusive forms of advertisements to exhibitors of the MEDICA.

You want to be part of the newsletter and reach over 30.000 interested readers with your advertising message? Then contact us at medica@beta-web.de or call us: 0049 – 228 9193735.

For more information on our available forms of advertisements, please see our Media Kit.
Website of beta-web GmbH
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Joachim Schäfer, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.